Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners


Other names: BioNTech | BioNTech AG | BioNTech SE | Neon Therapeutics | Neon Therapeutics, Inc. | BioNTech US Inc. | BioNTech US Inc | BioNTech US | BioNTech Diagnostics GmbH | BioNTech Diagnostics | Neon Therapeutics Inc | Neon Therapeutics Inc. | Neon Therapeutics, Inc | Biopharmaceutical New Technologies (BioNTech)
Related tests:


Cerca Biotech announces ISO 13485:2016 certification (EIN Presswire)
"Cerca Biotech...announced that its quality management system (QMS) has achieved ISO 13485:2016 certification for the design and development, production and distribution of in vitro diagnostics and software for molecular testing."
Cerca Biotech acquires MammaTyper® for molecular classification of breast cancer (EIN Presswire)
"Cerca Biotech GmbH...announced an asset purchase agreement with BioNTech Diagnostics AG...relating to MammaTyper®, a molecular diagnostics for breast cancer subtyping. Under the agreement, Cerca will acquire from BioNTech its rights and interest in MammaTyper® and the associated nucleic acid extraction kit RNXtract®. Cerca will be responsible for the development and commercialization of the products worldwide."
Licensing / partnership
MammaTyper® Kit